Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (T

TEMRA cells brain metastases cytomegalovirus (CMV) glioblastoma infection radiotherapy

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
04 02 2023
Historique:
received: 29 11 2022
revised: 20 01 2023
accepted: 01 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Radiotherapy (RT) of the brain is a common treatment for patients with high-grade gliomas and brain metastases. It has previously been shown that reactivation of cytomegalovirus (CMV) frequently occurs during RT of the brain. This causes neurological decline, demands antiviral treatment, and is associated with a worse prognosis. CMV-specific T cells are characterized by a differentiated effector memory phenotype and CD45RA+ CCR7- effector memory T (T

Identifiants

pubmed: 36831183
pii: cells12040516
doi: 10.3390/cells12040516
pmc: PMC9954596
pii:
doi:

Substances chimiques

Receptors, CCR7 0
Leukocyte Common Antigens EC 3.1.3.48
CCR7 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Immun Ageing. 2018 Nov 08;15:27
pubmed: 30455721
Curr Opin Immunol. 2009 Aug;21(4):440-5
pubmed: 19535233
PLoS One. 2017 May 8;12(5):e0177405
pubmed: 28481945
Aging Cell. 2016 Apr;15(2):389-92
pubmed: 26696322
Rev Med Virol. 2009 Jan;19(1):47-56
pubmed: 19035529
J Immunol. 2017 Feb 15;198(4):1748-1758
pubmed: 28069807
Nat Commun. 2017 Nov 13;8(1):1473
pubmed: 29133794
Immun Ageing. 2008 Jul 25;5:6
pubmed: 18657274
Blood. 2003 Sep 1;102(5):1779-87
pubmed: 12750165
J Exp Med. 2005 Sep 5;202(5):673-85
pubmed: 16147978
Age (Dordr). 2013 Jun;35(3):563-72
pubmed: 22252437
Aging Cell. 2022 May;21(5):e13607
pubmed: 35397197
Clin Cancer Res. 2020 Jul 1;26(13):3259-3270
pubmed: 32060103
Strahlenther Onkol. 2021 Jul;197(7):601-613
pubmed: 33884441
J Am Soc Nephrol. 2020 Apr;31(4):876-891
pubmed: 32165419
Blood. 2003 Jun 1;101(11):4260-6
pubmed: 12576317
Exp Gerontol. 2016 May;77:87-95
pubmed: 26883338
Int J Mol Sci. 2016 Aug 11;17(8):
pubmed: 27529227
Nature. 1999 Oct 14;401(6754):708-12
pubmed: 10537110
Neuro Oncol. 2016 Dec;18(12):1664-1672
pubmed: 27286796
Curr HIV Res. 2022 Aug 12;20(2):129-136
pubmed: 35170409
J Immunol. 2017 Nov 1;199(9):3187-3201
pubmed: 28972094
Strahlenther Onkol. 2021 Mar;197(3):246-256
pubmed: 33103231
J Gen Virol. 2011 Dec;92(Pt 12):2746-2756
pubmed: 21813708
Int J Mol Sci. 2018 Nov 13;19(11):
pubmed: 30428512
Clin Transplant. 2019 Sep;33(9):e13512
pubmed: 30817026
Annu Rev Immunol. 2004;22:745-63
pubmed: 15032595
Methods Mol Biol. 2019;1904:189-212
pubmed: 30539471
J Exp Med. 1997 Nov 3;186(9):1407-18
pubmed: 9348298
Methods Enzymol. 2020;632:389-415
pubmed: 32000906

Auteurs

Ilka Scheer (I)

Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Ina Becker (I)

Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.

Charlotte Schmitter (C)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.

Sabine Semrau (S)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.

Rainer Fietkau (R)

Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.

Udo S Gaipl (US)

Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.

Benjamin Frey (B)

Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.

Anna-Jasmina Donaubauer (AJ)

Translational Radiobiology, Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH